Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Drug-drug interaction between warfarin and statins: A Danish cohort study

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Obesity-induced CYP2E1 activity in children

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Higher chlorzoxazone clearance in obese children compared with nonobese peers

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Initiation of statin treatment is suggested to increase the international normalised ratio (INR) among warfarin users. However, available data is limited and conflicting. We conducted a register-based cohort study to evaluate the drug-drug interaction between warfarin and statins. By linking data on INR measurements and filled prescriptions, we identified warfarin users 2000-2015 initiating simvastatin (n=1,363), atorvastatin (n=165), or rosuvastatin (n=23). Simvastatin initiation led to an increase in mean INR from 2.40 to 2.71, with INRs peaking after 4 weeks, corresponding to a mean change of 0.32 (95%CI 0.25-0.38). High-dose and low-dose simvastatin led to comparable changes (mean change 0.33 vs 0.29). Initiation of atorvastatin and rosuvastatin lead to INR increases of 0.27 (95%CI 0.12-0.42) and 0.30 (95%CI -0.09-0.69). In conclusion, initiation of simvastatin, atorvastatin, or rosuvastatin among warfarin users led to a minor increase in INR. The magnitude of this change is for most patients likely of limited clinical relevance.

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Publication statusPublished - 2020

Bibliographical note

© 2020 The British Pharmacological Society.

    Research areas

  • anticoagulants and warfarin, drug interactions, statins

ID: 60052930